Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: A major update of a Cochrane review

Stroke

Volumn 34, Issue 9, 2003, Pages 2308-2309

  Roos, Yvo ^a   Rinkel, Gabriel ^b   Vermeulen, Marinus ^a   Algra, Ale ^b   Van Gijn, Jan ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Academic Medical Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; PLACEBO; TRANEXAMIC ACID;

ANEURYSM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONVALESCENCE; DRUG EFFECT; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; HYDROCEPHALUS; MORTALITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; BRAIN ISCHEMIA; HUMANS; HYDROCEPHALUS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0042418462     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000089030.04120.0E     Document Type: Review

References (1)

1. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE, Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771-778.